Innovent Biologics Inc.
1801Biotechnology
HK$81.60+0.43%As of Oct 29vs prior close
- Market cap
- $18.1B
- P/E (TTM)
- 98.0×
- P/E (FY1)
- 49.0×
- From 52W high
- −25.68%
- EPS (TTM)
- –
- Revenue (LTM)
- CN¥15.7B
- Net margin
- 7.85%
Nomior Score
65
Steady ProfileTop 17% of the scored universe
Growth79
Quality65
Value42
Momentum57
Resilience53
Growth
+41.98%revenue a year over 3 fiscal years
YE22 CN¥4.6BLTM CN¥15.7B
Connections
Revenue to profitYE25
6% of revenue became net profit, up 7 pts on a year.